Welcome to the EDRN! The Early Detection Research Network (EDRN), an initiative of the National Cancer Institute (NCI), brings together dozens of institutions to help accelerate the translation of biomarker information into clinical applications and to evaluate new ways of testing cancer in its earliest stages and for cancer risk. |
Announcement 08/20/2009
The RFAs for the Biomarker Development Laboratories, Biomarker Reference Laboratories, Clinical Validation Centers, and the Data Management and Coordinating Center have been released. Letters of intent due by Sept 29, 2009; applications due by Oct 29, 2009. More information NCI will hold a pre-application meeting for the 4 EDRN-component RFAs on Sept 29, 2009, in Bethesda, MD. The meeting will also be available via web cast. Detailed information (Posted 2009-08-20)
[Archives]
[Archives]
|
A Service of the National Cancer Institute |
 |
Scientific Components